China Valganciclovir API Factory

In the past few years, our company absorbed and digested advanced technologies both at home and abroad. Meanwhile, our company staffs a team of experts devoted to the development of Valganciclovir API,CAS NO 175865-59-5,175865-59-5,Valganciclovir, Now we have a skilled team for international trade. We will solve the problem you meet. We can present the goods you want. Be sure to feel cost-free to contact us.
Valganciclovir API, We severely promise that we give all the customers with the best quality products and solutions, the most competitive prices and the most prompt delivery. We hope to win a resplendent future for customers and ourselves.

Hot Products

  • 6-broMo-2-chloro-8-cyclopentyl-5-Methylpyrido[2,3-d]pyriMidin-7(8H)-one

    6-broMo-2-chloro-8-cyclopentyl-5-Methylpyrido[2,3-d]pyriMidin-7(8H)-one

    Product Name:6-broMo-2-chloro-8-cyclopentyl-5-Methylpyrido[2,3-d]pyriMidin-7(8H)-one
    Molecular Formula:C13H13BrClN3O
    Molecular Weight:342.62
    CAS Registry Number:1016636-76-2
  • Pentyl chloroformate

    Pentyl chloroformate

    Product Name:Pentyl chloroformate
    Molecular Formula:C6H11ClO2
    Molecular Weight:150.6
    CAS Registry Number;638-41-5
  • Atropine

    Atropine

    Product Name:Atropine
    Molecular Formula:C17H23NO3
    Molecular Weight;289.37
    CAS Registry Number;51-55-8
  • Diethyl phenylmalonate

    Diethyl phenylmalonate

    Product Name:Diethyl phenylmalonate
    Molecular Formula:C13H16O4
    Molecular Weight:236.26
    CAS Registry Number:83-13-6
  • Prednisolone

    Prednisolone

    Product Name:Prednisolone
    Molecular Formula:C21H28O5
    Molecular Weight:360.45
    CAS Registry Number;50-24-8
  • (-)-Diisopinocampheyl chloroborane

    (-)-Diisopinocampheyl chloroborane

    Product Name:(-)-Diisopinocampheyl chloroborane
    Molecular Formula:C20H34BCl
    Molecular Weight:320.75
    CAS Registry Number:85116-37-6

Send Inquiry

X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept